Unity Biotechnology appoints Tozier as Chief Strategy Officer
PremiumThe FlyUnity Biotechnology appoints Tozier as Chief Strategy Officer
4M ago
Outlook Therapeutics announces U.K. MHRA marketing authorization for LYTENAVA
Premium
The Fly
Outlook Therapeutics announces U.K. MHRA marketing authorization for LYTENAVA
4M ago
Outlook Therapeutics management to meet virtually with BTIG
Premium
The Fly
Outlook Therapeutics management to meet virtually with BTIG
5M ago
Outlook Therapeutics files to sell 2.78M shares of common stock for holders
PremiumThe FlyOutlook Therapeutics files to sell 2.78M shares of common stock for holders
7M ago
Four new option listings on April 17th
Premium
The Fly
Four new option listings on April 17th
7M ago
Outlook Therapeutics files $300M mixed securities shelf
Premium
The Fly
Outlook Therapeutics files $300M mixed securities shelf
8M ago
Outlook Therapeutics Inc trading resumes
PremiumThe FlyOutlook Therapeutics Inc trading resumes
8M ago
Outlook Therapeutics Inc trading halted, volatility trading pause
Premium
The Fly
Outlook Therapeutics Inc trading halted, volatility trading pause
8M ago
Outlook Therapeutics announces CHMP of EMA issued positive opinion on ONS-5010
Premium
The Fly
Outlook Therapeutics announces CHMP of EMA issued positive opinion on ONS-5010
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100